AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29182412 — intervention group
Group type: EXPERIMENTAL
Intervention: Water loading
Number of subjects: 21
Study 29182412 — intervention group
Group type: COMPARATOR
Intervention: Water loading and control
Number of subjects: 21
Study 28068834 — intervention group
Group type: EXPERIMENTAL
Intervention: Light sedation
Number of subjects: 0
Study 28068834 — intervention group
Group type: COMPARATOR
Intervention: Heavy sedation
Number of subjects: 0
Study 26248357 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg cadazolid BID
Number of subjects: 84
Study 26248357 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg cadazolid BID
Number of subjects: 84
Study 26248357 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mg cadazolid BID
Number of subjects: 84
Study 26248357 — intervention group
Group type: COMPARATOR
Intervention: 125 mg vancomycin QID
Number of subjects: 84
Study 26248357 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadazolid (all dosages)
Number of subjects: 84
Study 26248357 — intervention group
Group type: COMPARATOR
Intervention: Cadazolid and vancomycin
Number of subjects: 84
Study 26248357 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadazolid
Number of subjects: 84
Study 23347400 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-low-dose vaginal estriol 0.03 mg in combination with Lactobacillus acidophilus KS400 (Gynoflor(®) vaginal tablets)
Number of subjects: 87
Study 23347400 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 23347400 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-low-dose vaginal estriol 0.03 mg in combination with Lactobacillus acidophilus KS400 (Gynoflor(®) vaginal tablets) during maintenance therapy
Number of subjects: 87
Study 21937987 — intervention group
Group type: EXPERIMENTAL
Intervention: Voriconazole
Number of subjects: 16
Study 21937987 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir
Number of subjects: 16
Study 18226399 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous N-acetylcysteine (NAC) during hemodialysis
Number of subjects: 40
Study 18226399 — intervention group
Group type: COMPARATOR
Intervention: Hemodialysis alone (Control)
Number of subjects: 40
Study 18226399 — intervention group
Group type: COMPARATOR
Intervention: Comparison of NAC vs. Hemodialysis alone
Number of subjects: 40
Study 16606393 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose fluoroscopy regime
Number of subjects: 235
Study 14720434 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis
Number of subjects: 884
Study 14720434 — intervention group
Group type: COMPARATOR
Intervention: Anticoagulation
Number of subjects: 884
Study 10952951 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg/d)
Number of subjects: 60
Study 10952951 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 8772759 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone 750 mg/day for 48 hours before cardioversion
Number of subjects: 100
Study 8772759 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 1408320 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (1000 mg, orally)
Number of subjects: 32
Study 1408320 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipyrine (1000 mg, orally)
Number of subjects: 32
Study 1408320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 3892996 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous indomethacin 100 mg
Number of subjects: 20
Study 3892996 — intervention group
Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 20
Study 31533906 — intervention group
Group type: EXPERIMENTAL
Intervention: Patiromer (8·4 g once daily)
Number of subjects: 295
Study 31533906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 295
Study 29192000 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine patch
Number of subjects: 90
Study 29192000 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrronium liquid
Number of subjects: 90
Study 27385502 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical high-dose combination of clonidine (0.1%) + pentoxifylline (5%)
Number of subjects: 69
Study 27385502 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical low-dose combination of clonidine (0.04%) + pentoxifylline (2%)
Number of subjects: 69
Study 27385502 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.1%) alone
Number of subjects: 69
Study 27385502 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (5%) alone
Number of subjects: 69
Study 27385502 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatments for both low-dose and high-dose combinations
Number of subjects: 69
Study 27385502 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose combination of clonidine + pentoxifylline
Number of subjects: 69
Study 25042266 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial (TR) approach
Number of subjects: 260
Study 25042266 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral (TF) approach
Number of subjects: 260
Study 22435321 — intervention group
Group type: EXPERIMENTAL
Intervention: Waterpik Water Flosser (WF) plus manual tooth brushing
Number of subjects: 82
Study 22435321 — intervention group
Group type: COMPARATOR
Intervention: Sonicare Air Floss (AF) plus manual tooth brushing
Number of subjects: 82
Study 20482830 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 135
Study 20482830 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in executive functions and falls-related self-efficacy
Number of subjects: 135
Study 18628468 — intervention group
Group type: EXPERIMENTAL
Intervention: PF‐3512676
Number of subjects: 24
Study 18628468 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 24
Study 15892287 — intervention group
Group type: EXPERIMENTAL
Intervention: Qingyuan decoction combined with antibiotics
Number of subjects: 96
Study 15892287 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics alone
Number of subjects: 96
Study 12131831 — intervention group
Group type: EXPERIMENTAL
Intervention: Snoezelen sensory environment
Number of subjects: 0
Study 12131831 — intervention group
Group type: COMPARATOR
Intervention: Traditional relaxation
Number of subjects: 0
Study 10428519 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg aspirin daily for > or = 14 days
Number of subjects: 99
Study 10428519 — intervention group
Group type: COMPARATOR
Intervention: Placebo for > or = 14 days
Number of subjects: 99
Study 7752866 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (Se), N = 12, during a 10-week endurance training program.
Number of subjects: 24
Study 7752866 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pla), N = 12, during a 10-week endurance training program.
Number of subjects: 24
Study 7752866 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (both groups), N = 24.
Number of subjects: 24
Study 2298828 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine (2 mg/h constant i.v. infusion for 5 days, 120 mg/day orally for another 16 days)
Number of subjects: 27
Study 2298828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 12085574 — intervention group
Group type: EXPERIMENTAL
Intervention: Reuse of plastic disposable needle-syringe units
Number of subjects: 0
Study 12085574 — intervention group
Group type: COMPARATOR
Intervention: Glass syringes with daily new needles
Number of subjects: 0
Study 31683132 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR) and music therapy
Number of subjects: 112
Study 31683132 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - took the exam as usual
Number of subjects: 112
Study 31855202 — intervention group
Group type: EXPERIMENTAL
Intervention: Acculink stents
Number of subjects: 50
Study 31855202 — intervention group
Group type: COMPARATOR
Intervention: CGuard stents
Number of subjects: 50
Study 27669524 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening colonoscopy
Number of subjects: 1355692
Study 27669524 — intervention group
Group type: COMPARATOR
Intervention: No screening
Number of subjects: 1355692
Study 26467764 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 sessions of aerobic exercise at preferred intensity alongside treatment as usual
Number of subjects: 87
Study 26467764 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual only
Number of subjects: 87
Study 23300303 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus subtilis PB6 at 500 g/t of feed, containing 5 × 10(11) cfu/kg
Number of subjects: 216
Study 23300303 — intervention group
Group type: COMPARATOR
Intervention: Infected control group (no supplementation)
Number of subjects: 216
Study 23300303 — intervention group
Group type: COMPARATOR
Intervention: Uninfected control group (no infection or supplementation)
Number of subjects: 216
Study 21408161 — intervention group
Group type: EXPERIMENTAL
Intervention: N. americanus infection
Number of subjects: 20
Study 21408161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 19248951 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted instruction (CAI) module
Number of subjects: 55
Study 19248951 — intervention group
Group type: COMPARATOR
Intervention: Internet review articles
Number of subjects: 55
Study 16838645 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon (IFN)‐alpha
Number of subjects: 0
Study 16838645 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant interferon therapy
Number of subjects: 0
Study 11494935 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant prescribing practices by nurse practitioners
Number of subjects: 0
Study 9269644 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino/Bic (1% amino acid, 34 mmol/l bicarbonate)
Number of subjects: 10
Study 9269644 — intervention group
Group type: EXPERIMENTAL
Intervention: Glu/Bic (1.5% glucose, 34 mmol/l bicarbonate)
Number of subjects: 10
Study 9269644 — intervention group
Group type: COMPARATOR
Intervention: Glu/Lac (1.5% glucose, 35 mmol/l lactate)
Number of subjects: 10
Study 8438972 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-led primary home care with a 24-hour service
Number of subjects: 183
Study 8438972 — intervention group
Group type: COMPARATOR
Intervention: Ordinary care
Number of subjects: 183
Study 3126508 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g l-carnitine (endovenous)
Number of subjects: 17
Study 3126508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 29673934 — intervention group
Group type: EXPERIMENTAL
Intervention: Wedged footwear insoles
Number of subjects: 30
Study 29673934 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial or lateral wedge footwear insoles
Number of subjects: 30
Study 25985369 — intervention group
Group type: EXPERIMENTAL
Intervention: Heel raise inlay (ViscoHeel; Bauerfeind)
Number of subjects: 101
Study 25985369 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy (eccentric exercise regime under physiotherapeutic supervision)
Number of subjects: 101
Study 25985369 — intervention group
Group type: COMPARATOR
Intervention: Wait and see protocol
Number of subjects: 101
Study 25034509 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol
Number of subjects: 151
Study 25034509 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal NSAID
Number of subjects: 151
Study 25034509 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 151
Study 25034509 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 151
Study 22371837 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chloramine T
Number of subjects: 30
Study 22371837 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0% chloramine T
Number of subjects: 30
Study 22371837 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% fluorosurfactant
Number of subjects: 30
Study 22371837 — intervention group
Group type: COMPARATOR
Intervention: Corega refreshing mint (control)
Number of subjects: 30
Study 20376498 — intervention group
Group type: EXPERIMENTAL
Intervention: Lightweight mesh
Number of subjects: 50
Study 20376498 — intervention group
Group type: COMPARATOR
Intervention: Heavyweight mesh
Number of subjects: 50
Study 18695424 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooled tip catheter
Number of subjects: 991
Study 18695424 — intervention group
Group type: COMPARATOR
Intervention: 8-mm tip catheter
Number of subjects: 991
Study 15970918 — intervention group
Group type: EXPERIMENTAL
Intervention: Around-the-clock (ATC) dosing of acetaminophen with codeine
Number of subjects: 80
Study 15970918 — intervention group
Group type: COMPARATOR
Intervention: As-needed (PRN) dosing of acetaminophen with codeine
Number of subjects: 80
Study 12775122 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g MCT (10M)
Number of subjects: 16
Study 12775122 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g MCT and 5 g LCT (5M5L)
Number of subjects: 16
Study 12775122 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g MCT in mayonnaise or margarine
Number of subjects: 16
Study 12775122 — intervention group
Group type: COMPARATOR
Intervention: 10 g LCT (10L)
Number of subjects: 16
Study 10512262 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational videotape (19-min duration)
Number of subjects: 100
Study 10512262 — intervention group
Group type: COMPARATOR
Intervention: Control group (no videotape)
Number of subjects: 100
Study 7744189 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose methylprednisolone (1 mg.kg‐1 q.d.)
Number of subjects: 47
Study 7744189 — intervention group
Group type: COMPARATOR
Intervention: High-dose methylprednisolone (6 mg.kg‐1 q.d.)
Number of subjects: 47
Study 16296709 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 1.25 mg once daily
Number of subjects: 136
Study 16296709 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 2.5 mg once daily
Number of subjects: 136
Study 16296709 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg once daily
Number of subjects: 136
Study 16296709 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg once daily
Number of subjects: 136
Study 16296709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 6125171 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 150 mg twice daily
Number of subjects: 10
Study 6125171 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg once daily
Number of subjects: 10
Study 6125171 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol 7.5 mg twice daily
Number of subjects: 10
Study 30378136 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated fine fragrance containing Lim‐OOHs at 1260 ppm (3.0 μg/cm2)
Number of subjects: 28
Study 30378136 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated fine fragrance containing Lim‐OOHs at 420 ppm (0.99 μg/cm2)
Number of subjects: 28
Study 30378136 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated fine fragrance containing Lim‐OOHs at 140 ppm (0.33 μg/cm2)
Number of subjects: 28
Study 30378136 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls exposed to the highest dose (1260 ppm)
Number of subjects: 28
Study 30014863 — intervention group
Group type: COMPARATOR
Intervention: α-tocopherol (α-TF)
Number of subjects: 71
Study 30014863 — intervention group
Group type: EXPERIMENTAL
Intervention: tocotrienol rich fraction (TRF)
Number of subjects: 71
Study 25527069 — intervention group
Group type: EXPERIMENTAL
Intervention: Two interventions, each of 1‐h duration, using behaviour change techniques (BCTs) including advocated attitude, anticipated success/regret, behaviour modelling and barrier identification
Number of subjects: 1830
Study 25527069 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1830
Study 25199060 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab (100 mg)
Number of subjects: 135
Study 21116607 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 0
Study 21116607 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 21116607 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 0
Study 19761925 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripartite osteotomy
Number of subjects: 50
Study 19761925 — intervention group
Group type: COMPARATOR
Intervention: Bipartite osteotomy
Number of subjects: 50
Study 17694911 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (benzodiazepine)
Number of subjects: 0
Study 17694911 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 0
Study 15177708 — intervention group
Group type: EXPERIMENTAL
Intervention: Dawn simulation (The Natural Alarm Clock, Outside In, Cambridge Ltd)
Number of subjects: 12
Study 15177708 — intervention group
Group type: COMPARATOR
Intervention: Control (no dawn simulation)
Number of subjects: 12
Study 15177708 — intervention group
Group type: EXPERIMENTAL
Intervention: Dawn simulation
Number of subjects: 12
Study 11474056 — intervention group
Group type: EXPERIMENTAL
Intervention: SACA - Parent Version
Number of subjects: 0
Study 11474056 — intervention group
Group type: EXPERIMENTAL
Intervention: SACA - administered to children aged 11 and older
Number of subjects: 0
Study 11474056 — intervention group
Group type: EXPERIMENTAL
Intervention: SACA - administered to children aged 9 and 10 years
Number of subjects: 0
Study 9754744 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcelain (P)
Number of subjects: 112
Study 9754744 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect resin composite (IC)
Number of subjects: 112
Study 9754744 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct resin composite (DC)
Number of subjects: 112
Study 9754744 — intervention group
Group type: EXPERIMENTAL
Intervention: Vital teeth
Number of subjects: 112
Study 9754744 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-vital teeth
Number of subjects: 112
Study 8000589 — intervention group
Group type: EXPERIMENTAL
Intervention: 19 mm or 21 mm St. Jude Medical prosthesis
Number of subjects: 80
Study 8000589 — intervention group
Group type: COMPARATOR
Intervention: 23 mm or larger bileaflet prostheses
Number of subjects: 80
Study 8000589 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 3396298 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate
Number of subjects: 33
Study 3396298 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate
Number of subjects: 33
Study 3396298 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminohexane diphosphonate
Number of subjects: 33
Study 3396298 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate in hypoparathyroid patients
Number of subjects: 33
Study 31495881 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg or 25 mg
Number of subjects: 7010
Study 31495881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7010
Study 30581173 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-developed intervention bundle
Number of subjects: 22
Study 30581173 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study 27183915 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligation of the appendicular base with Lapro‐Clips (L‐C group)
Number of subjects: 1100
Study 27183915 — intervention group
Group type: COMPARATOR
Intervention: Ligation of the appendicular base with Hem‐o‐lok Clips (H‐C group)
Number of subjects: 1100
Study 24355439 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (Lactobacillus casei 01, 10^8 CFU daily for 8 weeks)
Number of subjects: 46
Study 22536930 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral treatment
Number of subjects: 225
Study 22536930 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 225
Study 22536930 — intervention group
Group type: EXPERIMENTAL
Intervention: Both antiretroviral and antidepressant treatment
Number of subjects: 225
Study 22536930 — intervention group
Group type: COMPARATOR
Intervention: Antiretroviral adherence
Number of subjects: 225
Study 22536930 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant adherence
Number of subjects: 225
Study 20660052 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (25, 50, 125, 300, and 600 mg) administered weekly for 20 weeks
Number of subjects: 109
Study 18337713 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict blood pressure control and dietary protein restriction
Number of subjects: 1666
Study 15735108 — intervention group
Group type: EXPERIMENTAL
Intervention: DMM (daily multiple micronutrient supplements)
Number of subjects: 284
Study 15735108 — intervention group
Group type: EXPERIMENTAL
Intervention: WMM (2 adequate intakes of multiple micronutrient on 1 day plus 6 days of placebo)
Number of subjects: 284
Study 15735108 — intervention group
Group type: EXPERIMENTAL
Intervention: DI (10 mg of iron supplement daily)
Number of subjects: 284
Study 15735108 — intervention group
Group type: COMPARATOR
Intervention: Placebo (daily placebo supplement)
Number of subjects: 284
Study 12846338 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg once daily for 12 weeks
Number of subjects: 1719
Study 12846338 — intervention group
Group type: COMPARATOR
Intervention: Placebo once daily for 12 weeks
Number of subjects: 1719
Study 10228127 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled leukotriene D4 (LTD4)
Number of subjects: 10
Study 10228127 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 10
Study 10228127 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen
Number of subjects: 10
Study 10228127 — intervention group
Group type: EXPERIMENTAL
Intervention: LTD4
Number of subjects: 10
Study 8689812 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg itraconazole orally once a day for 4 days
Number of subjects: 12
Study 8689812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2014978 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalosporin (various types)
Number of subjects: 108
Study 2014978 — intervention group
Group type: EXPERIMENTAL
Intervention: Mezlocillin
Number of subjects: 108
Study 2014978 — intervention group
Group type: COMPARATOR
Intervention: No antimicrobial agent (Control)
Number of subjects: 108
Study 7138736 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaramide
Number of subjects: 13